Janssens Kristel, Boussemaere Magaly, Wagner Stefan, Kopka Klaus, Denef Carl
Laboratory of Cell Pharmacology, University of Leuven, Medical School, Campus Gasthuisberg (O & N), B-3000 Leuven, Belgium.
Endocrinology. 2008 May;149(5):2391-402. doi: 10.1210/en.2007-1397. Epub 2008 Jan 17.
Catecholamines directly stimulate GH, ACTH, and prolactin secretion from rat anterior pituitary through the beta(2)-adrenoceptor (AR). We recently showed that gonadotrophs express the beta(1)-AR and that glucocorticoids drastically increase its mRNA expression level. The present investigation explores whether beta(1)-ARs are functionally coupled to adenylate cyclase. In anterior pituitary cell aggregates, the highly selective beta(1)-AR antagonists CGP 20712A and ICI 89,406-8a attenuated isoproterenol-stimulated cAMP accumulation, but no agonist action of norepinephrine could be detected. Remarkably, CGP 20712A inhibited basal cAMP levels by its own for at least 50%, an action that tended to be more effective in dexamethasone-supplemented medium. The latter effect was abolished by the beta-AR antagonist carvedilol, but not by other beta-AR antagonists. Pretreatment with pertussis toxin abolished the action of CGP 20712A on basal cAMP. CGP 20712A also attenuated isoproterenol-induced cAMP accumulation in the gonadotroph cell lines alphaT3-1 and LbetaT2, but not in the somatotroph precursor cell line GHFT and the folliculo-stellate cell line TtT/GF. However, in LbetaT2 cells CGP 20712A did not inhibit basal cAMP levels by its own. The present data suggest that beta(1)-AR in the anterior pituitary is positively coupled to adenylyl cyclase but is constitutively active in a pertussis toxin-sensitive manner. CGP 20712A may act as an inverse agonist with approximately 50% negative intrinsic activity, suggesting that the beta(1)-AR significantly contributes to basal adenylate cyclase activity in the pituitary.
儿茶酚胺通过β(2)-肾上腺素能受体(AR)直接刺激大鼠垂体前叶分泌生长激素、促肾上腺皮质激素和催乳素。我们最近发现促性腺激素细胞表达β(1)-AR,并且糖皮质激素可显著提高其mRNA表达水平。本研究探讨β(1)-AR是否在功能上与腺苷酸环化酶偶联。在垂体前叶细胞聚集体中,高选择性β(1)-AR拮抗剂CGP 20712A和ICI 89,406-8a可减弱异丙肾上腺素刺激的环磷酸腺苷(cAMP)积累,但未检测到去甲肾上腺素的激动剂作用。值得注意的是,CGP 20712A自身可使基础cAMP水平至少降低50%,在补充地塞米松的培养基中这种作用往往更有效。β-AR拮抗剂卡维地洛可消除后一种作用,但其他β-AR拮抗剂则不能。用百日咳毒素预处理可消除CGP 20712A对基础cAMP的作用。CGP 20712A还可减弱异丙肾上腺素诱导的促性腺激素细胞系αT3-1和LβT2中的cAMP积累,但在生长激素前体细胞系GHFT和滤泡星状细胞系TtT/GF中则无此作用。然而,在LβT2细胞中,CGP 20712A自身并不能抑制基础cAMP水平。目前的数据表明,垂体前叶中的β(1)-AR与腺苷酸环化酶呈正偶联,但以百日咳毒素敏感的方式组成性激活。CGP 20712A可能作为一种具有约50%负性内在活性的反向激动剂,提示β(1)-AR对垂体中基础腺苷酸环化酶活性有显著贡献。